Compound K Promotes Megakaryocytic Differentiation by NLRP3 Inflammasome Activation
Biomolecules · 04.10.2024 · 14 (10) · 1257
DOI: 10.3390/biom14101257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 04.10.2024. Verfasst von Seonhwa Hwang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Kyungsung University, 309 Suyeong-ro, Busan 48434, Republic of Korea. Hauptthemen laut MEDLINE: Megakaryocytes, Cell Differentiation, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health & Welfare, Republic of Korea, National Research Foundation of Korea (NRF), Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI).
Abstract (Originalsprache)
Platelets are essential blood components that maintain hemostasis, prevent excessive bleeding, and facilitate wound healing. Reduced platelet counts are implicated in various diseases, including leukemia, hepatitis, cancer, and Alzheimer’s disease. Enhancing megakaryocytic differentiation is a promising strategy to increase platelet production. Compound K (CK), a major bioactive metabolite of ginsenosides from Panax ginseng, has demonstrated anti-cancer and neuroprotective properties. In this study, we investigated the effects of CK on megakaryocytic differentiation and apoptosis in chronic myeloid leukemia (CML) cell lines K562 and Meg-01. CK treatment significantly upregulated the mRNA expression of key megakaryocytic differentiation markers, including CD61, CD41, and CD42a, and promoted the formation of large, multinucleated cells in K562 cells. Additionally, flow cytometry analysis revealed that CK at 5 µM induced apoptosis, a critical process in thrombocytopoiesis, in both K562 and Meg-01 cells. RT2 Profiler PCR array analysis further identified a marked increase in the expression of genes associated with the activation of the NLRP3 inflammasome in CK-treated K562 and Meg-01 cells. This study is the first to demonstrate that CK promotes megakaryocytic differentiation and apoptosis through the activation of the ERK/EGR1 and NLRP3 inflammasome pathways. These findings suggest that CK may enhance platelet production, indicating its potential as a therapeutic candidate for platelet-related disorders and other associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Kyungsung University, 309 Suyeong-ro, Busan 48434, Republic of Korea.
- Brain Busan 21 Plus Research Project Group, Kyungsung University, Busan 48434, Republic of Korea.
- College of Engineering, North Carolina A&T State University, Greensboro, NC 27411, USA.
- Chemical, Biological, and Bioengineering Department, North Carolina A&T State University, Greensboro, NC 27411, USA.
ORCID-Profile: Seonhwa Hwang, Anthony Junhoe Koo, Eunsoo Yoo
Förderung
- Ministry of Health & Welfare, Republic of Korea
- National Research Foundation of Korea (NRF)
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
- National Research Foundation of Korea (NRF) grant funded by the Korea government
Zitieren
APA
Hwang, S., Park, M. S., Koo, A. J., Yoo, E., Song, S. H., Kim, H. K., Park, M. H., & Kang, J. S. (2024). Compound K Promotes Megakaryocytic Differentiation by NLRP3 Inflammasome Activation. Biomolecules, 14(10), 1257. https://doi.org/10.3390/biom14101257
Vancouver
Hwang S, Park MS, Koo AJ, Yoo E, Song SH, Kim HK, et al. Compound K Promotes Megakaryocytic Differentiation by NLRP3 Inflammasome Activation. Biomolecules. 2024;14(10):1257. doi:10.3390/biom14101257
BibTeX
@article{Hwang2024,
author = {Hwang, Seonhwa and Park, Min-Seo and Koo, Anthony Junhoe and Yoo, Eunsoo and Song, Seh-Hyon and Kim, Hye-Kyung and Park, Min-Hi and Kang, Jae-Seon},
title = {Compound K Promotes Megakaryocytic Differentiation by NLRP3 Inflammasome Activation},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {10},
pages = {1257},
doi = {10.3390/biom14101257}
}
EUVIMED